Abstract
Immunodeficient mouse strains with and without a functional mouse interleukin (IL)-2 receptor gamma chain (mouse IL-2Rγ chain) are used to generate humanized mice. Common strains for this purpose include nonobese diabetic (NOD)/severe combined immune deficiency (SCID) mice which have functional mouse IL-2Rγ chain as well as NOD/SCID IL-2Rγc knockout (NOG or NSG) mice and Rag2null IL-2Rγcnull (Rag2γc) mice which lack this molecule. Until recently, the role of the mouse IL-2Rγ chain in lymphoid tissue development and human reconstitution had been underappreciated in the field of humanized mouse research. The goals of this article are to consolidate information on this topic to aid researchers in choosing the most appropriate mouse strain for their specific application from the many strains of immunodeficient mice available. An example of the impact of a functional mouse IL-2Rγ chain on lymphoid tissue development and human reconstitution is the differential intestinal humanization between bone marrow-liver-thymus (BLT) mice generated using NOD/SCID or NSG mice. NOD/SCID-BLT mice, which have an intact mouse IL-2Rγ chain, exhibit significantly higher levels of intestinal humanization versus NSG-BLT mice. This distinction highlights how immunodeficient mouse strains that show improved systemic human engraftment due to the lack of a mouse IL-2Rγ chain may exhibit deficiencies in human engraftment in specific tissues.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
The development of humanized mouse models has dramatically expanded the research landscape by facilitating in vivo modeling of many human diseases [1–23]. Different humanized mouse models have been bioengineered for these studies. Differences between humanized mouse models can include the immunodeficient mouse strain manipulated and whether the human hematopoietic stem cell (hHSC) transplant only or the bone marrow-liver-thymus (BLT) humanization strategy was utilized. To achieve the best experimental outcomes possible, it is critical that key attributes of different pairings of a given humanization protocol (e.g., hHSC only or BLT) with specific strains of immunodeficient mice be considered. As an aid in this process, this review compares lymphoid tissue development and human reconstitution among different human reconstitution strategies performed in mouse strains with or without a mouse interleukin (IL)-2Rγ chain. To best characterize the role of the mouse IL-2Rγ chain in lymphoid tissue development and human reconstitution, particular emphasis has been placed on reviewing manuscripts that include direct comparisons between humanized mice generated in immunodeficient mouse strains with or without a mouse IL-2Rγ chain.
2 Immunodeficient Mouse Strains and Humanization Strategies
A key consideration in the generation of humanized mice is the choice of immunodeficient mouse strain. In the mid-1990s, nonobese diabetic (NOD) mice were crossed with severe combined immunodeficient (SCID) mice to develop NOD/SCID mouse strains [24, 25]. Bone marrow engraftment of NOD/SCID mice with human hematopoietic stem cells (NOD/SCID-hHSC) results in a self-renewing source of human B cells, monocyte/ macrophages, dendritic cells , and natural killer (NK) cells that systemically reconstitute the transplanted mouse [26–28]. When planning experiments with NOD/SCID mice, it is important to consider the facts that the endogenous mouse thymus in these animals is vestigial such that it cannot produce human T cells following hHSC engraftment and that the lifespan of these animals is limited due to their predisposition to develop thymic lymphomas [25, 29]. Despite these constraints, the high and sustained levels of human myeloid, dendritic and B cells in NOD/SCID-hHSC have made this model useful for a variety of applications [6, 17, 28]. The lack of human T cells in NOD/SCID-hHSC mice led to the development of a combination approach, which would permit the development of a more complete human immune system (including human T cells) in humanized mice. BLT humanized mice are bioengineered by a bone marrow transplant of hHSC that is paired with the implantation under the renal capsule of autologous human liver and thymus [30, 31]. In BLT mice, the implanted human thymic tissue develops into a human thymus (also referred to as a thymic organoid) with normal human thymic structure and function [30–33]. T cell progenitors migrate to this thymus, mature into human leukocyte antigen (HLA)-restricted human T cells, exit the thymus, systemically populate the BLT mouse and perform effector functions such as HLA-restricted responses to Epstein–Barr virus (EBV) and HIV [31, 34].
The mouse IL-2Rγ chain is an essential component in the receptors for six different cytokines (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) [35]. Additional immunodeficient mouse strains have been developed that exhibit improved hHSC engraftment by modifying NOD/SCID [36, 37] and Rag2 knockout [38, 39] mice to prevent mouse IL-2Rγ chain function. Two different NOD/SCID IL-2Rγ chain mice have been developed and are designated as NOG [36] and NSG [37] mice. When compared to NOD/SCID mice, NOG and NSG mice are slightly more radiosensitive, do not develop thymic lymphomas, and consequently have a longer lifespan [37]. Both neonate and adult mice lacking the mouse IL-2Rγ chain have been transplanted with hHSC leading to humanization [40–42]. One of the most important differences between mice lacking a functional mouse IL-2Rγ chain and NOD/SCID mice is that the endogenous mouse thymus in NOG, NSG and Rag2γc mice supports human T cell production leading to systemic reconstitution of these mice with human T cells together with human B cells, human monocyte/macrophages, human dendritic cells, and human NK cells [41–43].
3 Primary and Secondary Lymphoid Tissues
Several reports have discussed the human reconstitution of the bone marrow, thymus, and spleen in humanized mice [23, 44, 45]. However, only four published studies report direct comparisons in the human reconstitution of these tissues between mice with and without a functional IL-2Rγ chain [36, 41, 46, 47]. The approach taken for the comparisons in three of these reports was to transplant similar numbers of hHSC into NOG or NSG mice and mice from the isogenic parent NOD/SCID stain [36, 41, 47]. Ito et al., Hiramatsu et al., and McDermott et al. each used NOD/SCID-hHSC and NOG-hHSC mice for their comparison [36, 41, 47]. McDermott et al. also used NSG-hHSC mice [47]. Their consensus findings were that transplantation of equal numbers of hHSC into NOG and NSG mice yielded significantly higher human reconstitution levels in the peripheral blood, bone marrow and spleen relative to NOD/SCID mice [36, 41, 47]. In addition, the production of human T cells by the mouse thymus was confirmed in the NOG-hHSC mice [41, 47] and NSG-hHSC mice [47].
In the fourth report [46], each humanized mouse was generated utilizing an optimized number of hHSC which is very different from the strategy tested in the other three reports. Specifically, NOD/SCID-BLT mice were transplanted with approximately 10 times more hHSC compared to NSG-BLT, NSG-hHSC, and Rag2γc-hHSC. Under these optimized conditions, the absolute numbers of splenic human T cells were not significantly different between these four types of humanized mice and limited differences were observed in the numbers of human T cell in bone marrow [46]. This paper did report that the human thymus present in BLT mice harbors a greater number of human thymocytes compared to a mouse thymus in hHSC transplant only mice [46]. A key point for consideration in the design and interpretation of experiments utilizing NSG-BLT mice is that human thymopoiesis in these animals occurs in both the implanted human thymus and the endogenous mouse thymus with the majority of human thymocytes present in the human thymus [46]. The fact that NSG-BLT mice have two separate locations with ongoing human thymopoiesis suggests that T cells in these mice could be heterogeneous in their restrictions which could complicate some experimental analyses.
Together, the available literature supports the conclusion that the presence or absence of a mouse IL-2Rγ chain does not impact humanization of bone marrow or spleen regardless of whether the hHSC transplant only or BLT method of humanization is utilized (Fig. 6.1). Regarding the endogenous mouse thymus in these strains, the production of human T cells from a mouse thymus only occurs in mice without a functional mouse IL-2Rγ chain [26–28, 40–43]. The development of a human thymus does not depend on the presence or absence of a mouse IL-2Rγ chain. Rather transplant of human tissues, as in BLT mice, is required for development of a human thymus (Fig. 6.1).
The mouse IL-2Rγ chain is a component of the IL-7 receptor [35] . This molecule is important, but dispensable, for lymph node organogenesis [48]. Since many humanized mice are bioengineered in mice lacking an IL-2Rγ chain, we examined the literature and found that the presence of lymph nodes in humanized mice has been reported in at least 44 manuscripts [3, 9, 10, 16, 19, 30, 31, 34, 37, 41–43, 46, 49–79]. Specific lymph nodes identified include: cervical [9, 30, 37, 74, 75, 77], mediastenal [75], axillary [9, 30, 37, 76], brachial [30, 37, 76], renal [30]; iliac [3], inguinal [30, 37, 76], mesenteric [3, 9, 19, 30, 41–43, 46, 65–71, 76, 78], and popliteal [79]. The most commonly reported lymph nodes in humanized mice are the mesenteric, cervical, axillary, and brachial. Why lymph nodes in the caudal region of humanized mice are less common has not been determined. The fact that 39 of these 44 manuscripts utilized mouse IL-2Rγ chain deficient mouse strains and still were able to detect lymph nodes [3, 9, 10, 16, 19, 30, 34, 37, 41–43, 46, 49, 50, 52–54, 56–72, 74–78] confirms that a functional mouse IL-2Rγ chain is dispensable for lymph node organogenesis [48] in humanized mice.
One critical function of secondary lymphoid tissues (i.e., spleen and lymph nodes) is to facilitate the development of humoral immune responses . The broad B cell repertoires [80–83] and antigen-specific human antibody responses [9, 34, 54, 55, 73, 84, 85] that have been reported in different types of humanized mice indicates that these animals have some degree of spleen and lymph node function in this regard, although T cell help has clearly not been optimized in these models [57, 81, 85, 86]. Shultz et al. suggested that human T cells in humanized mice may require thymic selection with HLA in order to provide adequate T cell help to B cells for T-dependent antibody production [87], yet T-dependent antibody production has been reported in humanized mice lacking human thymic stroma for T cell education [9, 88]. Furthermore, there is a question of whether lymphoid follicles and germinal centers, anatomical regions that facilitate T cell help, are present within the secondary lymphoid tissues of humanized mice. Lymphoid follicles and germinal center-like structures have been reported to be both present [16, 30, 31, 41, 43, 89] and absent [8, 37, 82] in humanized mice. Beyond direct observation with immunohistochemistry approaches, B cell development and function has been used as a surrogate marker for the presence of lymphoid follicles and germinal centers in humanized mice. A post-germinal center surface phenotype on B cells in humanized mice has been reported [9, 88] while others have identified B cells as maturing independent of a germinal center [68, 85, 90]. In summary, further work is required to reach a consensus regarding the development of lymphoid follicles and germinal centers in humanized mice and to define any role of the mouse IL-2Rγ chain in these processes.
4 Intestinal Lymphoid Tissues
At least 15 manuscripts have examined the presence of human immune cells within intestines of humanized mice [34, 43, 46, 59, 61, 70, 73, 77, 91–97]. For hHSC transplant only mice, the results reported lack both quantitation and a broad analysis of the different human hematopoietic lineages present in the mouse intestines [43, 70, 91–94, 97]. In contrast, several groups have reported that multiple lineages of human immune cells (including T cells, B cells, macrophages, NK cells, and dendritic cells) are distributed through the intestines of BLT mice [34, 73, 77, 95]. To fully characterize the differential intestinal humanization between various humanize mice, one manuscript reported direct, quantitative comparisons of intestinal humanization between NOD/SCID-BLT, NSG-BLT, NSG-hHSC and Rag2γc-hHSC mice [46]. Quantified intestinal cell populations in this report included the lamina propria lymphocytes (LPL) and intraepithelial lymphocytes (IEL) from both the small intestine (SI) and large intestine (LI): SI LPL; SI IEL; LI LPL; and LI IEL. NOD/SCID BLT mice exhibited the highest numbers of human T cells in each of these four intestinal populations [46]. Regardless of the human reconstitution method (i.e., –BLT or –hHSC transplant only), intestinal T cell levels were consistently lower when the immunodeficient mouse strain used lacked a functional IL-2Rγ chain (Fig. 6.1) [46]. These data indicate that the presence of a functional mouse IL-2Rγ chain is critical for robust intestinal human T cell engraftment.
The intestinal immune system is composed of gut-associated lymphoid tissue (GALT) (e.g., Peyer’s patches and isolated lymphoid follicles) and intestinal lamina propria. Many humanized mice are bioengineered in mice lacking an IL-2Rγ chain (a component of the IL-7 receptor) and IL-7 signaling in lymphoid tissue organizer cells and lymphoid tissue inducer cells is indispensible for GALT organogenesis [98–104]. Therefore, we examined the literature for reports describing the presence of GALT in humanized mice. One manuscript reported undefined lymphoid aggregates (e.g., isolated lymphoid follicles) in the intestines of NOD/SCID-BLT mice [73]. These aggregates contained CD4+ T cells , macrophages, and dendritic cells and were susceptible to HIV-induced pathology [73]. Given that the humanized mouse research field is so heavily reliant upon immunodeficient mice without a functional mouse IL-2Rγ chain and there are translational research questions regarding human GALT pathologies that could be studied if humanized mice exhibit GALT structures, defining the presence or absence of GALT in different types of humanized mice is a very important area of future study.
5 Conclusions
Lymphocyte migration into and egress from lymphoid tissues is the result of a series of poorly understood but highly complex species-specific interactions between cell adhesion molecules, integrins, chemokine receptors, and chemokines. Here we discussed the remarkable observation that human lymphocytes traffic in humanized mice such that lymphoid tissues develop and are populated with human cells in these mice. For the bone marrow, thymus, spleen, and to a lesser extent lymph nodes, the presence of a functional mouse IL-2Rγ chain is dispensable for lymphoid tissue development and human reconstitution. However, utilization of the BLT humanization protocol on mice with and without a functional mouse IL-2Rγ chain has provided compelling evidence that this molecule is important for intestinal human reconstitution. Specifically, NOD/SCID-BLT mice have the highest levels of intestinal humanization relative to NSG-BLT mice, as well as to NSG-hHSC and Rag2γc-hHSC mice. Thus, immunodeficient mouse strains with improved hHSC engraftment may exhibit deficiencies in human reconstitution in certain tissues (e.g., intestines). Understanding these distinctions increases our ability to accurately interpret previously published humanized mouse data and to properly plan future experiments.
6 Future Directions
There are two major research areas for future investigation related to human lymphoid tissue development in humanized mice. First, a clear understanding of the cross-species activity for individual cytokines, chemokines, and adhesion molecules would offer critical insights into the optimal combination of human transgenes for appropriate human lymphoid tissue development. There are ongoing efforts by multiple research groups to apply human growth factors exogenously [65, 105–107] or develop mice that transgenically expressing human development and growth factors [108–111]. Yet a comprehensive description of cross-species activity is still lacking [112]. Second, when humanized mice are created by a transplant of hHSC only, all of the human cells present in these mice are hematopoietic in origin. The mice still lack nonhematopoietic cells (e.g., epithelial cells) that are involved in human immune development and function. Pairing current human reconstitution techniques with previously developed strategies for the implantation into mice of human tissues beyond the human thymus in BLT mice (e.g., human bone marrow and human intestines) could introduce additional nonhematopoietic cells into the humanize mouse models [113, 114]. Successful implementation of such strategies would provide the best possible environment for proper lymphoid tissue development in humanized mice.
References
King M, Pearson T, Rossini AA, Shultz LD, Greiner DL. Humanized mice for the study of type 1 diabetes and beta cell function. Ann N Y Acad Sci. 2008;1150:46–53.
Chang NH, Inman RD, Dick JE, Wither JE. Bone marrow-derived human hematopoietic stem cells engraft NOD/SCID mice and traffic appropriately to an inflammatory stimulus in the joint. J Rheumatol. 2010;37(3):496–502.
Kwant-Mitchell A, Ashkar AA, Rosenthal KL. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J Virol. 2009;83(20):10664–76.
Pedroza-Gonzalez A, Xu K, Wu T-C, Aspord C, Tindle S, Marches F, et al. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med. 2011;208(3):479–90.
Sellier-Leclerc AL, Duval A, Riveron S, Macher MA, Deschenes G, Loirat C, et al. A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol. 2007;18(10):2732–9.
Islas-Ohlmayer M, Padgett-Thomas A, Domiati-Saad R, Melkus MW, Cravens PD, Martin Mdel P, et al. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein–Barr virus. J Virol. 2004;78(24):13891–900.
Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, et al. A new model of Epstein–Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol. 2011;85(1):165–77.
Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, et al. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med. 2009;206(6):1423–34.
Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H, et al. A new humanized mouse model of Epstein–Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis. 2008;198(5):673–82.
Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, Frelinger JA, et al. A humanized mouse model to study Hepatitis C virus infection, immune response, and liver disease. Gastroenterology. 2011;140(4):1334–44.
Smith MS, Goldman DC, Bailey AS, Pfaffle DL, Kreklywich CN, Spencer DB, et al. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe. 2010;8(3):284–91.
Yu CI, Gallegos M, Marches F, Zurawski G, Ramilo O, Garcia-Sastre A, et al. Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. Blood. 2008;112(9):3671–8.
Libby SJ, Brehm MA, Greiner DL, Shultz LD, McClelland M, Smith KD, et al. Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella typhi infection. Proc Natl Acad Sci U S A. 2010;107(35):15589–94.
Song J, Willinger T, Rongvaux A, Eynon EE, Stevens S, Manz MG, et al. A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe. 2010;8(4):369–76.
Firoz Mian M, Pek EA, Chenoweth MJ, Ashkar AA. Humanized mice are susceptible to Salmonella typhi infection. Cell Mol Immunol. 2011;8(1):83–7.
Unsinger J, McDonough JS, Shultz LD, Ferguson TA, Hotchkiss RS. Sepsis-induced human lymphocyte apoptosis and cytokine production in “humanized” mice. J Leukoc Biol. 2009;86(2):219–27.
Bente DA, Melkus MW, Garcia JV, Rico-Hesse R. Dengue fever in humanized NOD/SCID mice. J Virol. 2005;79(21):13797–9.
Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, et al. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS ONE. 2009;4(10):e7251.
Kuruvilla JG, Troyer RM, Devi S, Akkina R. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology. 2007;369(1):143–52.
Mota J, Rico-Hesse R. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol. 2009;83(17):8638–45.
Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, Kumar P, et al. Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol. 2010;84(5):2490–501.
Vasilakis N, Cardosa J, Diallo M, Sall AA, Holmes EC, Hanley KA, et al. Sylvatic dengue viruses share the pathogenic potential of urban/endemic dengue viruses. J Virol. 2010;84(7):3726-7 (author reply 7–8).
Denton PW, Garcia JV. Humanized mouse models of HIV infection. AIDS Rev. 2011;13(3):135–48.
Koyanagi Y, Tanaka Y, Tanaka R, Misawa N, Kawano Y, Tanaka T, et al. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection. Leukemia. 1997;11(Suppl 3):109–12.
Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154(1):180–91.
Lowry PA, Shultz LD, Greiner DL, Hesselton RM, Kittler EL, Tiarks CY, et al. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol Blood Marrow Transplant. 1996 Feb;2(1):15–23.
Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2(12):1329–37.
Cravens PD, Melkus MW, Padgett-Thomas A, Islas-Ohlmayer M, Del P MM, Garcia JV. Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis. Stem Cells. 2005;23(2):264–78.
Greiner DL, Hesselton RA, Shultz LD. SCID Mouse models of human stem cell engraftment. Stem Cells. 1998;16(3):166–77.
Lan P, Tonomura N, Shimizu A, Wang S, Yang YG. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood. 2006;108(2):487–92.
Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006;12(11):1316–22.
McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241(4873):1632–9.
Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM. Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med. 1990;172(4):1055–63.
Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol. 2009;83(14):7305–21.
Leonard WJ. Cytokines and immunodeficiency diseases. Nat Rev Immunol. 2001;1(3):200–8.
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175–82.
Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174(10):6477–89.
Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, Thrasher AJ. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol. 1998;103(2):335–42 (130(5):662–70).
Mazurier F, Fontanellas A, Salesse S, Taine L, Landriau S, Moreau-Gaudry F, et al. A novel immunodeficient mouse model-RAG2 x common cytokine receptor gamma chain double mutants-requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J Interferon Cytokine Res. 1999;19(5):533–41.
Gimeno R, Weijer K, Voordouw A, Uittenbogaart CH, Legrand N, Alves NL, et al. Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells. Blood. 2004;104(13):3886–93.
Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, Katamura K, et al. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model. Blood. 2003;102(3):873–80.
Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304(5667):104–7.
Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood. 2005;106:1565–73.
Akkina R. New generation humanized mice for virus research: comparative aspects and future prospects. Virology. 2013;435(1):14–28.
Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012;12(11):786–98.
Denton PW, Nochi T, Lim A, Krisko JF, Martinez-Torres F, Choudhary SK, et al. IL-2 receptor gamma-chain molecule is critical for intestinal T-cell reconstitution in humanized mice. Mucosal Immunol. 2012;5(5):555–66.
McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood. 2010;116(2):193–200.
Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity. 1995;2(3):223–38.
Chateau ML, Denton PW, Swanson MD, McGowan I, Garcia JV. Rectal transmission of Transmitted/Founder HIV-1 is efficiently prevented by topical 1 % tenofovir in BLT humanized mice. PLoS ONE. 2013;8(3):e60024.
Sato K, Nie C, Misawa N, Tanaka Y, Ito M, Koyanagi Y. Dynamics of memory and naive CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1. Vaccine. 2010;28(Suppl 2):B32–7.
Onoe T, Kalscheuer H, Danzl N, Chittenden M, Zhao G, Yang YG, et al. Human natural regulatory T cell development, suppressive function, and postthymic maturation in a humanized mouse model. J Immunol. 2011;187(7):3895–903.
Dash PK, Gendelman HE, Roy U, Balkundi S, Alnouti Y, Mosley RL, et al. Long-acting NanoART elicits potent antiretroviral and neuroprotective responses in HIV-1 infected humanized mice. AIDS. 2012;26(17):2135-44
Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, et al. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood. 2007;109(1):212–8.
Sango K, Joseph A, Patel M, Osiecki K, Dutta M, Goldstein H. Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice. AIDS Res Hum Retroviruses. 2010;26(7):735–46.
Tonomura N, Habiro K, Shimizu A, Sykes M, Yang YG. Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood. 2008;111(8):4293–6.
Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, Mugishima H, et al. Humanized NOD/SCID/IL2R {gamma}null Mice Transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol. 2007;81(23):13259–64.
Lang J, Kelly M, Freed BM, McCarter MD, Kedl RM, Torres RM, et al. Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J Immunol. 2013;190(5):2090–101.
Joo SY, Chung YS, Choi B, Kim M, Kim JH, Jun TG, et al. Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells. Transplantation. 2012;94(11):1095–102.
Hur EM, Patel SN, Shimizu S, Rao DS, Gnanapragasam PN, An DS, et al. Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood. 2012;120(23):4571–82.
Zou W, Denton PW, Watkins RL, Krisko JF, Nochi T, Foster JL, et al. Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+ CD8+ thymocytes. Retrovirology. 2012;9(1):44.
Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, Wege AK, et al. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 2008;5(1):e16.
Denton PW, Olesen R, Choudhary SK, Archin NM, Wahl A, Swanson MD, et al. Generation of HIV latency in BLT humanized mice. J Virol. 2012;86(1):630–4.
Denton PW, Othieno F, Martinez-Torres F, Zou W, Krisko JF, Fleming E, et al. One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J Virol. 2011;85(15):7582–93.
Chateau M, Swanson MD, Garcia JV. Inefficient vaginal transmission of tenofovir resistant HIV-1. J Virol. 2013;87(2):1274–7.
Pek EA, Chan T, Reid S, Ashkar AA. Characterization and IL-15 dependence of NK cells in humanized mice. Immunobiology. 2010;216(1–2):218–24.
Ma SD, Yu X, Mertz JE, Gumperz JE, Reinheim E, Zhou Y, et al. An Epstein–Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol. 2012;86(15):7976–87.
Heuts F, Gavier-Widen D, Carow B, Juarez J, Wigzell H, Rottenberg ME. CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria. Proc Natl Acad Sci U S A. 2013;110(16):6482–7.
Scheeren FA, Nagasawa M, Weijer K, Cupedo T, Kirberg J, Legrand N, et al. T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells. J Exp Med. 2008;205(9):2033–42.
Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology. 2006;3:76.
Choudhary SK, Archin NM, Cheema M, Dahl NP, Garcia JV, Margolis DM. Latent HIV-1 infection of resting CD4(+) T cells in the humanized Rag2(-)/(-) gammac(-)/(-) mouse. J Virol. 2012;86(1):114–20.
Berges BK, Akkina SR, Remling L, Akkina R. Humanized Rag2(-/-) gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year. Virology. 2010;397(1):100–3.
Kalscheuer H, Danzl N, Onoe T, Faust T, Winchester R, Goland R, et al. A model for personalized in vivo analysis of human immune responsiveness. Sci Transl Med. 2012;4(125):125ra30.
Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, Wege AK, et al. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med. 2007;204(4):705–14.
Gorantla S, Makarov E, Finke-Dwyer J, Gebhart CL, Domm W, Dewhurst S, et al. CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. J Immunol. 2010;184(12):7082–91.
Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, West JT, et al. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J Virol. 2007;81(6):2700–12.
Legrand N, Huntington ND, Nagasawa M, Bakker AQ, Schotte R, Strick-Marchand H, et al. Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc Natl Acad Sci U S A. 2011;108(32):13224–9.
Wahl A, Swanson MD, Nochi T, Olesen R, Denton PW, Chateau M, et al. Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice. PLoS Pathog. 2012;8(6):e1002732.
Denton PW, Krisko JF, Powell DA, Mathias M, Kwak YT, Martinez-Torres F, et al. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS ONE. 2010;5(1):e8829.
Murooka TT, Deruaz M, Marangoni F, Vrbanac VD, Seung E, von Andrian UH, et al. HIV-infected T cells are migratory vehicles for viral dissemination. Nature. 2012;490(7419):283–7.
Ippolito GC, Hoi KH, Reddy ST, Carroll SM, Ge X, Rogosch T, et al. Antibody repertoires in humanized NOD-scid-IL2Rgamma(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS ONE. 2012;7(4):e35497.
Chang H, Biswas S, Tallarico AS, Sarkis PT, Geng S, Panditrao MM, et al. Human B-cell ontogeny in humanized NOD/SCID gammac(null) mice generates a diverse yet auto/poly- and HIV-1-reactive antibody repertoire. Genes Immun. 2012;13(5):399–410.
Becker PD, Legrand N, van Geelen CM, Noerder M, Huntington ND, Lim A, et al. Generation of human antigen-specific monoclonal IgM antibodies using vaccinated “Human Immune System” mice. PLoS ONE. 2010;5(10):e13137.
Marodon G, Desjardins D, Mercey L, Baillou C, Parent P, Manuel M, et al. High diversity of the immune repertoire in humanized NOD.SCID.gamma c-/- mice. Eur J Immunol. 2009;39(8):2136–45.
Jaiswal S, Pazoles P, Woda M, Shultz LD, Greiner DL, Brehm MA, et al. Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice. Immunology. 2012;136(3):334–43.
Biswas S, Chang H, Sarkis PT, Fikrig E, Zhu Q, Marasco WA. Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5(+) B cells. Immunology. 2011;134(4):419–33.
Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, Katano I, et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int Immunol. 2009;21(7):843–58.
Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M, et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc Natl Acad Sci U S A. 2010;107(29):13022–7.
Choi B, Chun E, Kim M, Kim ST, Yoon K, Lee KY, et al. Human B cell development and antibody production in humanized NOD/SCID/IL-2Rgamma(null) (NSG) mice conditioned by busulfan. J Clin Immunol. 2011;31(2):253–64.
Pearson T, Shultz LD, Miller D, King M, Laning J, Fodor W, et al. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol. 2008;154(2):270–84.
White RE, Ramer PC, Naresh KN, Meixlsperger S, Pinaud L, Rooney C, et al. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest. 2012;122(4):1487–502.
Waldron-Lynch F, Henegariu O, Deng S, Preston-Hurlburt P, Tooley J, Flavell R, et al. Teplizumab induces human gut-tropic regulatory cells in humanized mice and patients. Sci Transl Med. 2012;4(118):118ra12.
Hofer U, Baenziger S, Heikenwalder M, Schlaepfer E, Gehre N, Regenass S, et al. RAG2-/- gamma(c)-/- mice transplanted with CD34 + cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus. J Virol. 2008;82(24):12145–53.
Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol. 2010;28(8):839–47.
Berges BK, Akkina SR, Folkvord JM, Connick E, Akkina R. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice. Virology. 2008;373(2):342–51.
Ringpis GE, Shimizu S, Arokium H, Camba-Colon J, Carroll MV, Cortado R, et al. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice. PLoS ONE. 2012;7(12):e53492.
Shimizu S, Hong P, Arumugam B, Pokomo L, Boyer J, Koizumi N, et al. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood. 2010;115(8):1534–44.
Cimbro R, Vassena L, Arthos J, Cicala C, Kehrl JH, Park C, et al. IL-7 induces expression and activation of integrin alpha4beta7 promoting naive T-cell homing to the intestinal mucosa. Blood. 2012;120(13):2610–9.
Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol. 2003;3(4):292–303.
van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol. 2010;10(9):664–74.
Eberl G, Littman DR. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat + cells. Science. 2004;305(5681):248–51.
Eberl G. Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway?. Nat Rev Immunol. 2005;5(5):413–20.
Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin beta receptor, and TNF receptor I function. J Immunol. 2003;170(11):5475–82.
Ivanov II, Diehl GE, Littman DR. Lymphoid tissue inducer cells in intestinal immunity. Curr Top Microbiol Immunol. 2006;308:59–82.
Hamada H, Hiroi T, Nishiyama Y, Takahashi H, Masunaga Y, Hachimura S, et al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol. 2002;168(1):57–64.
Chen Q, Khoury M, Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci U S A. 2009;106(51):21783–8.
Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009;206(1):25–34.
van Lent AU, Dontje W, Pouw SM, Nagasawa M, Siamari R, Bakker AQ, Pouw SM, et al. IL-7 enhances thymic human T cell development in “human immune system” Rag2-/-IL-2Rgammac-/- mice without affecting peripheral T cell homeostasis. J Immunol. 2009;183(12):7645–55.
Willinger T, Rongvaux A, Strowig T, Manz MG, Flavell RA. Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends Immunol. 2011;32(7):321–7.
Ito R, Takahashi T, Katano I, Ito M. Current advances in humanized mouse models. Cell Mol Immunol. 2012;9(3):208–14.
Rongvaux A, Willinger T, Takizawa H, Rathinam C, Auerbach W, Murphy AJ, et al. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc Natl Acad Sci U S A. 2011;108(6):2378–83.
Billerbeck E, Barry WT, Mu K, Dorner M, Rice CM, Ploss A. Development of human CD4+ FoxP3+ regulatory T cells in human stem cell factor, GM-CSF and interleukin 3 expressing NOD SCID IL2R{gamma}NULL humanized mice. Blood. 2011;117(11):3076–86.
Manz MG. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity. 2007;26(5):537–41.
Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood. 1992;79(7):1704–11.
Zhang Z, Jin L, Champion G, Seydel KB, Stanley SL Jr. Shigella infection in a SCID mouse-human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine. Infect Immun. 2001;69(5):3240–7.
Acknowledgments
This work was supported in part by the University of North Carolina (UNC) Center for AIDS Research grant P30 AI50410; by National Institute of Health grants AI096113 and AI08263 (J.V.G.); and by a Research Fellowship of the Japan Society for the Promotion of Science (T.N.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Denton, P., Nochi, T., Garcia, J. (2014). Impact of the Mouse IL-2Rγ Chain on Lymphoid Tissue Development and Human Reconstitution in Immunodeficient Mice. In: Poluektova, L., Garcia, J., Koyanagi, Y., Manz, M., Tager, A. (eds) Humanized Mice for HIV Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1655-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1655-9_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1654-2
Online ISBN: 978-1-4939-1655-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)